1st Symposium on Functional Autoantibodies Targeting G-Protein-Coupled Receptors
Lübeck, October 07-09, 2016
Greeting from the symposium chair
Dear Sir or Madam, Dear colleagues,
It is a great pleasure to announce the first symposium on functional autoantibodies targeting G-protein-coupled receptors (GPCRs) in Lübeck. GPCRs are involved in a variety of physiological and pathophysiological processes. So far, much effort has been made on anti-GPCR drug discovery with a focus on the development of small molecules and monoclonal antibodies for the treatment of cancer, infection, metabolic disorders or inflammatory diseases. Recently, functional autoantibodies against GPCRs were identified in various diseases associated with pathogenesis, uncovering a potential new field of therapeutic intervention. Thus, the aim of this symposium is to combine the current knowledge about the role of GPCRs in different pathologies, their mode of action and state-of-the-art research techniques to identify common fundamental pathways that can be transferred to other disease entities with similar manifestations.
I cordially invite you to participate in this inspiring symposium with outstanding speakers from the field of GPCR research and constructive discussions as well as poster sessions. I look forward to welcome you to the beautiful Hanseatic City of Lübeck and encourage you and your colleagues to contribute to this exciting meeting.
Prof. Dr. Gabriela Riemekasten - Director, Department of Rheumatology -
Prof. Dr. Gabriela Riemekasten Department of Rheumatology University of Lübeck
Sponsors of the 1st RAB-Symposium
Disclosure of cooperation
Disclosure of payments made during the 1st RAB-Symposium In accordance with transparency obligations, we transparently present the services and the extent of support provided by companies to participants both in announcing and holding the congress.